Drug Type Small molecule drug |
Synonyms- |
Target |
Action stimulants |
Mechanism NR1H2 stimulants(nuclear receptor subfamily 1 group H member 2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | India | 15 Jun 2022 |